{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:03:41Z","timestamp":1791335021035,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.autrev.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T16:24:08Z","timestamp":1213374248000},"page":"156-159","source":"Crossref","is-referenced-by-count":85,"title":["Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation"],"prefix":"10.1016","volume":"8","author":[{"given":"Massimo","family":"Cugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2008.05.003_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0065-2776(04)82008-X","article-title":"The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation","volume":"82","author":"Davis","year":"2004","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.iac.2006.08.003","article-title":"Mechanism of angioedema in first complement component inhibitor deficiency","volume":"26","author":"Davis","year":"2006","journal-title":"Immunol Allergy Clin North Am."},{"key":"10.1016\/j.autrev.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1 inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clin Immunol Immunopathol"},{"issue":"6090","key":"10.1016\/j.autrev.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.autrev.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2008.05.003_bib7","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2008.05.003_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM198502283120902","article-title":"Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins.","volume":"312","author":"Geha","year":"1985","journal-title":"N Engl J Med."},{"issue":"22","key":"10.1016\/j.autrev.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","article-title":"Autoantibody-mediated acquired deficiency of C1 inhibitor","volume":"316","author":"Alsenz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000018252","article-title":"Acquired angioedema with C1 inhibitor deficiency: is the distinction between type I and type II still relevant?","volume":"199","author":"D'Incan","year":"1999","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.autrev.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2249.1996.d01-879.x","article-title":"Autoimmune C1-inhibitor deficiency","volume":"106","author":"Whaley","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI113934","article-title":"Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema","volume":"83","author":"Jackson","year":"1989","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.autrev.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.156.5.2009","article-title":"Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency","volume":"156","author":"He","year":"1996","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1172\/JCI112610","article-title":"Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients","volume":"78","author":"Zuraw","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.iy.06.040188.003115","article-title":"C1-inhibitor and hereditary angioneurotic edema","volume":"6","author":"Davis","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM198305053081802","article-title":"Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema","volume":"308","author":"Schapira","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1084\/jem.152.3.742","article-title":"Detection of active kallikrein in induced blister fluids of hereditary angioedema patients","volume":"152","author":"Curd","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","article-title":"Kinin formation in hereditary angioedema plasma: evidence against kinin derivative from C2 and in support of spontaneous formation of bradykinin","volume":"72","author":"Fields","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2008.05.003_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2249.1994.tb06009.x","article-title":"Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities","volume":"95","author":"Shoemaker","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2008.05.003_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2008.05.003_bib24","first-page":"38","article-title":"Generation of plasmin during acute attacks of hereditary angioedema","volume":"121","author":"Cugno","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib25","first-page":"129","article-title":"Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin","volume":"120","author":"Kleniewsky","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1 inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.autrev.2008.05.003_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.autrev.2008.05.003_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.autrev.2008.05.003_bib29","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2008.05.003_bib30","first-page":"e104","article-title":"Acquired angioedema: a new target for rituximab?","volume":"89","author":"Ziakas","year":"2004","journal-title":"Haematologica"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:19:10Z","timestamp":1684441150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1568997208000797"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.05.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}